Survey of serum procalcitonin in cirrhotic patients

Acta Medica Iranica

Volumn 51, Issue 3, 2013, Pages 153-156

  Rahimkhani, Monireh ^a   Einollahi, Nahid ^a   Daneshvar, Hossein Khavari ^a   Dashti, Nasrin ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cirrhosis; Infection; Procalcitonin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; PROCALCITONIN; ANTIINFECTIVE AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALCITONIN; PROTEIN PRECURSOR;

ALCOHOL LIVER CIRRHOSIS; ARTICLE; BACTERIAL INFECTION; BLOOD DONOR; CONTROLLED STUDY; HEALTH SURVEY; HEPATITIS B; HEPATITIS C; HOSPITAL ADMISSION; HUMAN; IMMUNOASSAY; IMMUNOLUMINOMETRIC ASSAY; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; NEOPLASM; SEPSIS; ADULT; BLOOD; CASE CONTROL STUDY; FEMALE; MALE; METABOLISM;

ADULT; ALANINE TRANSAMINASE; ANTI-BACTERIAL AGENTS; ASPARTATE AMINOTRANSFERASES; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; PROTEIN PRECURSORS;

EID: 84886823118     PISSN: 00446025     EISSN: 17359694     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Hatzistilianou M. Diagnostic and prognostic role of procalcitonin in infections. Scientific World Journal 2010; 10:1941-6.
2. Morgenthaler NG, Struck J, Chancerelle Y, Weglohner W, Agay D, Bohuon, C. Production of procalcitonin (PCT) in non thyroidal tissue after LPS injection. Horm Metab Res 2003;35: 290-295.
3. Balog A, Ocsovszki I, Mandi Y. Flowcytometric analysis of Procalcitonin expression in human monocytes and granulocytes. Immunol Lett 2002;84:199-203.
4. Russwurm S, Stonans I, Stonane E, Wiederhold M, LuberA, Zipfel PF, et al. Procalcitonin and CGRP-1 mRNA expression in Various human tissues. Shock 2001;16:109-12.
5. Husova L, Husa P, Senkyrik M, Lata J. Procalcitonin as an indicator of infection in patients with liver cirrhosis. Vnitr Lek 2004 Feb;50(2):153-6.
6. Oshita H, Sakurai J, Kamitsuna M. Semi-quantitative procalcitonin test for the diagnosis of bacterial infection: clinical use and experience in Japan. J Microbial Immunol Infect 2010;43(3):222-7.
7. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546-54.
8. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-10.
9. World Health Organization (WHO). WHO report on infectious disease: removingobstacles to healthy development. Geneva: WHO,1999. www.who.int/infectious-disease-report/index
10. Rahimkhani M, Ghofrani H. Helicobacterpylori and peptic ulcer in cirrhotic patients. Pak J Med Scien 2008;24(6):84952.
11. Kim MH, Lim G, Kang SY, Lee WI, Suh JT, Lee HJ. Utility of procalcitonin as an early diagnostic marker of bacteremia in patients with acute fever. Yonsei med J 2011;5(2):276-81.
12. Rahimkhani M, Khavari Daneshvar H, Jamali S. Serologic evaluation of hepatitis B and D in patients with cirrhosis. African J Microb Research 2011; 5(5):568-571.
13. Michalik DE, Duncan BW, Mee RBB, Worley S, Goldfarb J, Danziger-Isakov LA, Davis SJ, Harrison AM, Appachi E, Sabella C. Quantitative analysis of procalcitonin after pediatriccardiothoracic surgery. Cardiol Young 2006;16:48-53.
14. Bienvenu J, Monneret G. Procalcitonin as an acute phase marker. Ann Clin Biochem 2001; 38:483-93.
15. Nijsten MW, Olinga P, The TH. Procalcitonin behaves as a fastresponding acute phase protein in vivo and in vitro. Crit Care Med 2000; 28:458-61.
16. Oberhoffer M, Stonans I, Russwurm S. Procalcitonin expressionin human peripheral blood mononuclear cells and its modulation bylipopolysaccharides and sepsisrelated cytokines in vitro. J Lab Clin Med 1999; 134:49-55.
17. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J, Whicher J. Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-analysis. Clinical Infectious Diseases 2004; 39:206-17.
18. Elefsiniotis IS, Petrocheilou A, Scarmeas N, Ketikoglou I, Pantazis KD, Toutouza M, Tsianos EV. Serum procalcitonin levels in chronic hepatitis C patients under pegylated interferon-alpha plus ribavirin treatment. Journal of Clinical Virology 2006;37:329-31
19. Oruc N, Ozutemiz O, Yuce G, Akarca US, Ersoz G, Gunsar F, Batur Y. Serum procalcitonin and CRP levels in non-alcoholic fatty liver disease: a case control study. BMC Gastroenterology 2009;9:16.
20. Viallon A, Guyomarc'h P, Guyomarc'h S, Tardy B, Robert F, Marjollet O. Decrease in serum procalcitonin levels over time during treatment of acute bacterial meningitis. Crit Care 2005;9(4):R344-R350.
21. Stojanović-Spehar S, Blazeković-Milaković S, Bergman-Marković B, Vrca-Botica M. Prescribing antibiotics to preschool children in primary health care in Croatia. Coll Antropol 2008;32(1):125-30.